Nu Skin EVP Disposes 20,000 Shares; Weighted Avg Price $11.97

Rhea-AI Filing Summary

Nu Skin Enterprises insider sale summary. EVP and General Counsel Chayce Clark reported a sale of 20,000 shares of Class A common stock on 09/03/2025 at a weighted-average price of $11.97 per share. After the reported disposition, the reporting person beneficially owned 233,140 shares, held directly. The Form 4 shows no derivative transactions and was signed by an attorney-in-fact on behalf of the reporting person on 09/04/2025. The filing includes an explanation that the reported price is a weighted average from multiple trades between $11.96 and $12.01.

Insights

Securities Analyst

TL;DR: Officer sold a modest stake—transaction appears routine and disclosed promptly.

The sale of 20,000 shares represents a disclosed, non-derivative disposition by an executive officer reported on Form 4. The weighted-average price of $11.97 is documented and the filing states trades occurred within $11.96 to $12.01. Post-transaction direct ownership remains at 233,140 shares, which maintains the officer's continued stake in the company. There are no derivative instruments reported that could complicate the ownership picture. From a market-impact perspective, the filing alone conveys a routine insider liquidity event rather than a categorical change in control or governance.

Corporate Governance Expert

TL;DR: Disclosure practices meet Section 16 requirements; transaction raises no immediate governance red flags.

The Form 4 identifies the reporting person as EVP and General Counsel and documents the sale clearly, including a weighted-average price range and an undertaking to provide per-trade details if requested. The presence of an attorney-in-fact signature indicates use of a delegated filing process but does not alter the substantive disclosure. No related-party, derivative, or plan-based transactions are noted on this filing, simplifying oversight. Overall, the filing adheres to required transparency standards for insider transactions.

Insider Trade Summary

Net Seller: 20,000 shares

Net Sell 1 txn

Insider Clark Chayce David

Role EVP and General Counsel

Sold 20,000 shs ($239K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	20,000	$11.97	$239K

Holdings After Transaction: Class A Common Stock — 233,140 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.96 to $12.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 09/04/2025 - 05:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Clark Chayce David

(Last) (First) (Middle)

C/O NU SKIN ENTERPRISES, INC.

75 W CENTER STREET

(Street)

PROVO UT 84601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/03/2025		S		20,000	D	$11.97(1)	233,140	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.96 to $12.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

	/s/ Gregory Belliston as Attorney-in-Fact for Chayce Clark	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.